share_log

WAVE Life Sciences Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

WAVE Life Sciences Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

WAVE 生命科学股票:深入了解分析师观点(5 个评级)
Benzinga ·  05/15 09:01
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on WAVE Life Sciences (NASDAQ:WVE) in the last three months.
在过去三个月中,有5位分析师公布了对WAVE Life Sciences(纳斯达克股票代码:WVE)的评级,提供了从看涨到看跌的不同视角。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级,展示了过去30天内不断变化的情绪,并将其与前几个月进行了比较。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $13.4, along with a high estimate of $19.00 and a low estimate of $5.00. This current average reflects an increase of 14.82% from the previous average price target of $11.67.
分析师提供了更深入的见解,确定了12个月的目标股价,平均目标价为13.4美元,最高估计为19.00美元,低估值为5.00美元。目前的平均价格比之前的平均目标价11.67美元增长了14.82%。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析师评级:深度分析
A comprehensive examination of how financial experts...
对金融专家如何...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发